Loading…

PCN81 Cost-Effectiveness Analysis of Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous CELL Carcinoma in Patients Whose Tumor Expressed Programmed Death-Ligand 1 at Combined Positive Score ≥1 in France

Saved in:

Bibliographic Details
Published in:	Value in health 2020-12, Vol.23, p.S436-S436
Main Authors:	Massetti, M., Even, C., Geoffrois, L., Farge, G., Levy Bachelot, L., Borse, R., Chirovsky, D., Durand-Zaleski, I.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!